Back
Murphy USA 10K Form
Buy
57
MUSA
Murphy USA
Last Price:
544.56
Seasonality Move:
-0.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | MUSA/Murphy USA Quarterly |
| 2023-08-03 | 10Q | MUSA/Murphy USA Quarterly |
| 2023-05-04 | 10Q | MUSA/Murphy USA Quarterly |
| 2022-10-27 | 10Q | MUSA/Murphy USA Quarterly |
| 2022-07-28 | 10Q | MUSA/Murphy USA Quarterly |
| 2022-05-05 | 10Q | MUSA/Murphy USA Quarterly |
Receive MUSA News And Ratings
See the #1 stock for the next 7 days that we like better than MUSA
MUSA Financial Statistics
Sales & Book Value
| Annual Sales: | $21.53B |
|---|---|
| Cash Flow: | $65.2M |
| Price / Cash Flow: | 26 |
| Annual Sales: | $40.99 |
| Price / Book: | 12.96 |
Profitability
| EPS (TTM): | 24.24000 |
|---|---|
| Net Income (TTM): | $510M |
| Gross Margin: | $2.31B |
| Return on Equity: | 62.26% |
| Return on Assets: | 11.71% |
Murphy USA Earnings Forecast
Key Murphy USA Financial Ratios
- The Gross Profit Margin over the past 16 years for MUSA is 10.75%.
- The Selling, General & Administrative Expenses for MUSA have been equal to 1.12% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 17.69% of Operating Income.
- The Net Earning history of MUSA is 2.59% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 10 years.
Murphy USA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Specialty Retail |
| Sector: | Consumer Discretionary |
| Current Symbol: | MUSA |
| CUSIP: | 626755 |
| Website: | murphyusa.com |
Debt
| Debt-to-Equity Ratio: | 2.21 |
|---|---|
| Current Ratio: | 0.8 |
| Quick Ratio: | 0.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.85 |
|---|---|
| Forward P/E Ratio: | 19.36 |
MUSA Technical Analysis vs Fundamental Analysis
Buy
57
Murphy USA (MUSA)
is a Buy
Is Murphy USA a Buy or a Sell?
-
Murphy USA stock is rated a Buy
The current Murphy USA [MUSA] share price is $531.34. The Score for MUSA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.